Review article: Indeterminate colitis - Definition, diagnosis and management

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 1, 2007, Pages 13-17

  Tremaine, W J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TACROLIMUS; TIOGUANINE;

ANASTOMOSIS; CANCER RISK; COLITIS; COLON CANCER; COLON POUCH; COLON RESECTION; CROHN DISEASE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; ENTERITIS; HUMAN; INDETERMINATE COLITIS; NOMENCLATURE; PHENOTYPE; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SEROLOGY; SURGICAL TECHNIQUE; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ANASTOMOSIS, SURGICAL; COLITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROCTOCOLECTOMY, RESTORATIVE; REFERRAL AND CONSULTATION;

EID: 33845434714     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03159.x     Document Type: Review

References (34)

1. International Classifications of Diseases (ICD). World Heath Organization [Website]. 2006. Available at: http://www3.who.int/icd/currentversion/fr-icd. htm, accessed on 29 August 2006.
2. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease - 'colitis indeterminate'. J Clin Pathol 1978; 31: 567-77.
3. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868-71.
4. Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology 1987; 92: 181-5.
5. Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 1998; 22: 983-9.
6. Jarry M, Soussan EB, Boureille A, et al. The value of wireless capsule enteroscopy (WCE) in indeterminate colitis. Gastroenterology 2005; 128 (4 Suppl. 2): A-306.
7. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7.
8. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A): 5-36.
9. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
10. Wells AD, McMillan I, Price AB, Ritchie JK, Nicholls RJ. Natural history of indeterminate colitis. Br J Surg 1991; 78: 179-81.
11. Geboes K, De Hertogh G. Indeterminate colitis. Inflamm Bowel Dis 2003; 9: 324-31.
12. Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol 2003; 16: 347-58.
13. Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm Bowel Dis 2006; 12: 258-62.
14. Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002; 122: 1242-7.
15. Joossens S, Colombel JF, Landers C, et al. Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis. Gut 2006; epub ahead of print
16. Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment Pharmacol Ther 2003; 18: 741-7.
17. Gornet JM, Couve S, Hassani Z, et al. Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study. Aliment Pharmacol Ther 2003; 18: 175-81.
18. Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002; 8: 317-24.
19. Teml A, Schwab M, Harrer M, et al. A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis. Scand J Gastroenterol 2005; 40: 1205-13.
20. Rudolph WG, Uthoff SM, McAuliffe TL, Goode ET, Petras RE, Galandiuk S. Indeterminate colitis: the real story. Dis Colon Rectum 2002; 45: 1528-34.
21. Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum 2000; 43: 1487-96.
22. Dayton MT, Larsen KR, Christiansen DD. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Arch Surg 2002; 137: 690-4; discussion 694-5.
23. Marcello PW, Schoetz DJ Jr, Roberts PL, et al. Evolutionary changes in the pathologic diagnosis after the ileoanal pouch procedure. Dis Colon Rectum 1997; 40: 263-9.
24. Koltun WA, Schoetz DJ Jr, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Indeterminate colitis predisposes to perineal complications after ileal pouchanal anastomosis. Dis Colon Rectum 1991; 34: 857-60.
25. Atkinson KG, Owen DA, Wankling G. Restorative proctocolectomy and indeterminate colitis. Am J Surg 1994; 167: 516-8.
26. Bodzin JH, Klein SN, Priest SG. Ileoproctostomy is preferred over ileoanal pull-through in patients with indeterminate colitis. Am Surg 1995; 61: 590-3.
27. Hui T, Landers C, Vasiliauskas E, et al. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation. Dis Colon Rectum 2005; 48: 1254-62.
28. Hartley JE, Fazio VW, Remzi FH, et al. Analysis of the outcome of ileal pouchanal anastomosis in patients with Crohn's disease. Dis Colon Rectum 2004; 47: 1808-15.
29. Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996; 347: 854-7.
30. Shen B, Fazio VW, Remzi FH, Lashner BA. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol 2005; 100: 2796-807.
31. Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 2006; 130: 1941-9.
32. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
33. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000; 14: 145-53.
34. Levi GS, Harpaz N. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease. Am J Surg Pathol 2006; 30: 1022-9.